247
Views
72
CrossRef citations to date
0
Altmetric
Review

The use of TNF-α blocking agents in rheumatoid arthritis: an overview

&
Pages 581-594 | Published online: 02 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Yeong Wook Song, Yong-Beom Park & Jinseok Kim. (2021) LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 21:1, pages 1-8.
Read now
Muhammad Safwan Akram, Neelam Pery, Lucy Butler, Muhammad Imtiaz Shafiq, Nayab Batool, Muhammad Fayyaz ur Rehman, Luke G. Grahame-Dunn & Ali K. Yetisen. (2021) Challenges for biosimilars: focus on rheumatoid arthritis. Critical Reviews in Biotechnology 41:1, pages 121-153.
Read now
Srilakshmi M. Sharma, Achim R. Nestel, Richard W. J. Lee & Andrew D. Dick. (2009) Clinical Review: Anti-TNFα Therapies in Uveitis: Perspective on 5 Years of Clinical Experience. Ocular Immunology and Inflammation 17:6, pages 403-414.
Read now
Sabina A Antoniu, Florin Mihaltan & Ruxandra Ulmeanu. (2008) Anti-TNF-α therapies in chronic obstructive pulmonary diseases. Expert Opinion on Investigational Drugs 17:8, pages 1203-1211.
Read now
Hye Kyung KIM, Myung-Gyou KIM & Kang-Hyun LEEM. (2008) Inhibitory Effects of Egg Yolk Soluble Protein on Bone Resorption. Bioscience, Biotechnology, and Biochemistry 72:7, pages 1929-1931.
Read now
Éric Toussirot & Daniel Wendling. (2007) The use of TNF-α blocking agents in rheumatoid arthritis: an update. Expert Opinion on Pharmacotherapy 8:13, pages 2089-2107.
Read now
Robin C Geletka & E William St Clair. (2005) Infliximab for the treatment of early rheumatoid arthritis. Expert Opinion on Biological Therapy 5:3, pages 405-417.
Read now
John B. Carey, Michelle A. Carey, Ashley Allshire & Frank N. van Pelt. (2005) Tipping the balance towards tolerance: The basis for therapeutic immune modulation by gold?. Autoimmunity 38:6, pages 393-397.
Read now
Daniel Wendling & Eric Toussirot. (2004) Anti-TNF-α therapy in ankylosing spondylitis. Expert Opinion on Pharmacotherapy 5:7, pages 1497-1507.
Read now

Articles from other publishers (62)

Viet Tram Duong, Mariusz Skwarczynski & Istvan Toth. (2023) Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant. Tuberculosis 139, pages 102307.
Crossref
Felicia Ceban & Jiaxi Xu. (2022) The Evolution of TNF-α Blockade for the Treatment of Rheumatoid Arthritis. Journal of Undergraduate Life Sciences 16:1.
Crossref
Diego Fresegna, Silvia Bullitta, Alessandra Musella, Francesca Romana Rizzo, Francesca De Vito, Livia Guadalupi, Silvia Caioli, Sara Balletta, Krizia Sanna, Ettore Dolcetti, Valentina Vanni, Antonio Bruno, Fabio Buttari, Mario Stampanoni Bassi, Georgia Mandolesi, Diego Centonze & Antonietta Gentile. (2020) Re-Examining the Role of TNF in MS Pathogenesis and Therapy. Cells 9:10, pages 2290.
Crossref
Ayse Ayzit Kilinc, Pinar Onal, Berrak Oztosun, Mehmet Yildiz, Amra Adrovic, Sezgin Sahin, Kenan Barut, Haluk Cokugras & Ozgur Kasapcopur. (2020) Determination of tuberculin skin test for isoniazid prophylaxis in BCG vaccinated children who are using anti‐TNF agents for rheumatologic diseases. Pediatric Pulmonology 55:10, pages 2689-2696.
Crossref
Mohammed Tayab Hussain, Asif Jilani Iqbal & Lucy Victoria Norling. (2020) The Role and Impact of Extracellular Vesicles in the Modulation and Delivery of Cytokines during Autoimmunity. International Journal of Molecular Sciences 21:19, pages 7096.
Crossref
Jiansong Tang, Wing-Cheong Yam & Zhiwei Chen. (2016) Mycobacterium tuberculosis infection and vaccine development. Tuberculosis 98, pages 30-41.
Crossref
Sermin Borekci, Ersan Atahan, Deniz Demir Yilmaz, Nejdiye Mazıcan, Berna Duman, Yesim Ozguler, Benan Musellim, Vedat Hamuryudan & Gul Ongen. (2015) Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment. Respiration 90:3, pages 191-198.
Crossref
Vicente Ruiz Garcia, Paresh Jobanputra, Amanda Burls, Juan B Cabello, Paloma Vela Casasempere, Sylvia Bort-Marti & Francis JB Kynaston-Pearson. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Renata B. Lacerda, Natália M. Sales, Leandro L. da Silva, Roberta Tesch, Ana Luisa P. Miranda, Eliezer J. Barreiro, Patricia D. Fernandes & Carlos A. M. Fraga. (2014) Novel Potent Imidazo[1,2-a]pyridine-N-Glycinyl-Hydrazone Inhibitors of TNF-α Production: In Vitro and In Vivo Studies. PLoS ONE 9:3, pages e91660.
Crossref
Xian-Zhe Dong, Dai-Hong Guo, Ping Liu, Li-Hua Mu, Xiao-Yue Ge, Hong-Jie Li & Xiao-Li Zheng. (2013) Effects of (20S*,24R*)-epoxy-9,19-cyclolanstane-3β,12β,16β,25-pentaol-3-O-β-d-xylopyranoside Extracted from Rhizoma Beesia on Immunoregulation and Anti-inflammation. Inflammation 37:1, pages 277-286.
Crossref
Benjamin Baur, Kirsten Storch, Kathrin E. Martz, Marcia I. Goettert, André Richters, Daniel Rauh & Stefan A. Laufer. (2013) Metabolically Stable Dibenzo[ b , e ]oxepin-11(6 H )-ones as Highly Selective p38 MAP Kinase Inhibitors: Optimizing Anti-Cytokine Activity in Human Whole Blood . Journal of Medicinal Chemistry 56:21, pages 8561-8578.
Crossref
Ozlem Kar Kurt, Bahar Kurt, Fahrettin Talay, Tuncer Tug, Mehmet Soy, Cemal Bes & Mutlu Hayran. (2013) Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosisMittel- bis Langzeit-Follow-up Ergebnisse einer Chemoprophylaxe mit INH vor einer Therapie mit anti-TNF alpha in einem Hochrisikogebiet für Tuberkulose. Wiener klinische Wochenschrift 125:19-20, pages 616-620.
Crossref
A Reddi. 2013. Articular Cartilage. Articular Cartilage 105 164 .
Caiyun Wang, Lei Li, Hong Guan, Saiyinna Tong, Mingqiang Liu, Chang Liu, Ziying Zhang, Chenguang Du & Peifeng Li. (2013) Effects of taurocholic acid on immunoregulation in mice. International Immunopharmacology 15:2, pages 217-222.
Crossref
Zhengzheng Zhang, Yuanjing Ding, Weiping Li, Bin Song & Rui Yang. (2013) Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis. Arthritis Research & Therapy 15:5, pages R169.
Crossref
Rafael Venson, Astrid Wiens, Cassyano Januário Correr & Roberto Pontarolo. (2012) Efficacy, safety and tolerability of using abatacept for the treatment of rheumatoid arthritis. Brazilian Journal of Pharmaceutical Sciences 48:4, pages 781-791.
Crossref
Weiyuan Chang. 2012. Antibody-Mediated Drug Delivery Systems. Antibody-Mediated Drug Delivery Systems 391 405 .
María Dolores Juárez-Rodríguez, Jiseon Yang, Rebin Kader, Praveen Alamuri, Roy CurtissIIIIII & Josephine E. Clark-Curtiss. (2012) Live Attenuated Salmonella Vaccines Displaying Regulated Delayed Lysis and Delayed Antigen Synthesis To Confer Protection against Mycobacterium tuberculosis. Infection and Immunity 80:2, pages 815-831.
Crossref
Aryeh Fischer & Roland M. du Bois. 2012. Diffuse Lung Disease. Diffuse Lung Disease 217 237 .
Inge R. Klein-Wieringa, Michael P. M. van der Linden, Rachel Knevel, Joanneke C. Kwekkeboom, Els van Beelen, Tom W. J. Huizinga, Annette van der Helm-van Mil, Margreet Kloppenburg, René E. M. Toes & Andreea Ioan-Facsinay. (2011) Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis & Rheumatism 63:9, pages 2567-2574.
Crossref
Mercè Pont-Giralt, Núria Godessart & Cristina Balagué. (2010) Differential Pharmacological Behaviour of p38 Inhibitors in Regulating the LPS-Induced TNF-α Production in Human and Rat Whole Blood In Vitro. Inflammation 34:2, pages 119-132.
Crossref
Vicente Ruiz Garcia, Paresh Jobanputra, Amanda Burls, Juan B Cabello, José G Gálvez Muñoz, Encarnación SC Saiz Cuenca & Anne Fry-Smith. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
I. Zidi, A. Bouaziz, W. Mnif, A. Bartegi, F. A. Al-Hizab & N. B. Amor. (2010) Golimumab Therapy of Rheumatoid Arthritis: An Overview. Scandinavian Journal of Immunology 72:2, pages 75-85.
Crossref
Heidi A. Schreiber, Paul D. Hulseberg, JangEun Lee, Jozsef Prechl, Peter Barta, Nora Szlavik, Jeffrey S. Harding, Zsuzsanna Fabry & Matyas Sandor. (2010) Dendritic Cells in Chronic Mycobacterial Granulomas Restrict Local Anti-Bacterial T Cell Response in a Murine Model. PLoS ONE 5:7, pages e11453.
Crossref
Catherine M. Krall, Xiujuan Yao, Martha A. HassCarlos Feleder & Alexandre A. Steiner. (2010) Food deprivation alters thermoregulatory responses to lipopolysaccharide by enhancing cryogenic inflammatory signaling via prostaglandin D 2 . American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 298:6, pages R1512-R1521.
Crossref
Andreas P Lysandropoulos & Renaud A Du Pasquier. (2010) Demyelination as a complication of new immunomodulatory treatments. Current Opinion in Neurology 23:3, pages 226-233.
Crossref
Daniel H. Zimmerman, Patricia Taylor, Alison Bendele, Roy Carambula, Yvonne Duzant, Valeria Lowe, Sean P. O'Neill, Eyal Talor & Kenneth S. Rosenthal. (2010) CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model. International Immunopharmacology 10:4, pages 412-421.
Crossref
Nicolas Hunzelmann. 2010. Therapy of Skin Diseases. Therapy of Skin Diseases 427 432 .
Sabina Antonela Antoniu. (2009) Cytokine Antagonists for the Treatment of Asthma. BioDrugs 23:4, pages 241-251.
Crossref
Ronggai Sun, Yasir A.W. Skeiky, Angelo Izzo, Veerabadran Dheenadhayalan, Zakaria Imam, Erica Penn, Katherine Stagliano, Scott Haddock, Stefanie Mueller, John Fulkerson, Charles Scanga, Ajay Grover, Steven C. Derrick, Sheldon Morris, David M. Hone, Marcus A. Horwitz, Stefan H.E. Kaufmann & Jerald C. Sadoff. (2009) Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine 27:33, pages 4412-4423.
Crossref
Osman Elbek, Meral Uyar, Neriman Aydın, Şermin Börekçi, Nazan Bayram, Hasan Bayram & Öner Dikensoy. (2008) Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha. Clinical Rheumatology 28:4, pages 421-426.
Crossref
Aryeh Fischer, Kevin K. Brown & Stephen K. Frankel. (2009) Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease. Clinical Pulmonary Medicine 16:2, pages 74-80.
Crossref
Pin-Yu Perera, Steven C. Derrick, Kristopher Kolibab, Fumiki Momoi, Masafumi Yamamoto, Sheldon L. Morris, Thomas A. Waldmann & Liyanage P. Perera. (2009) A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine 27:15, pages 2121-2127.
Crossref
Yi Wan, Shifang Yuan, Xiaochang Xue, Meng Li, Xin Qin, Cun Zhang, Weihua Wang, Changli Jiang, Shouzhen Wu, Yan Liu, Wenhua Zhu, Yonggang Ran, Zhen Zhang, Wei Han & Yingqi Zhang. (2009) The preventive effect of adjuvant-free administration of TNF-PADRE autovaccine on collagen-II-induced rheumatoid arthritis in mice. Cellular Immunology 258:1, pages 72-77.
Crossref
Terry J. SmithChieh Chih TsaiMei-Ju ShihShanli TsuiBeiling ChenRui HanVibha NaikChris S. KingChris PressShweta KamatRobert A. GoldbergRichard P. PhippsRaymond S. DouglasAndrew G. Gianoukakis. (2008) Unique Attributes of Orbital Fibroblasts and Global Alterations in IGF-1 Receptor Signaling Could Explain Thyroid-Associated Ophthalmopathy. Thyroid 18:9, pages 983-988.
Crossref
Jong‐Seob Kil, Myung‐Gyou Kim, Hye Mi Choi, Jong‐Pil Lim, Yungmin Boo, Ee‐Hwa Kim, Jeung‐Beum Kim, Hye Kyung Kim & Kang‐Hyun Leem. (2008) Inhibitory effects of Angelicae Gigantis Radix on osteoclast formation. Phytotherapy Research 22:4, pages 472-476.
Crossref
Sun Jin Hur & Yeonhwa Park. (2007) Effect of conjugated linoleic acid on bone formation and rheumatoid arthritis. European Journal of Pharmacology 568:1-3, pages 16-24.
Crossref
Jalal A. Jazayeri, Nicole De Weerd, Warren Raye, Tony Velkov, Lanie Santos, David Taylor & Graeme J. Carroll. (2007) Generation of mutant leukaemia inhibitory factor (LIF)–IgG heavy chain fusion proteins as bivalent antagonists of LIF. Journal of Immunological Methods 323:1, pages 1-10.
Crossref
Jiyoun Kim & Daniel G. Remick. (2007) Tumor necrosis factor inhibitors for the treatment of asthma. Current Allergy and Asthma Reports 7:2, pages 151-156.
Crossref
Frank N. A. M. van Pelt, Michelle A. Carey & John B. Carey. 2007. Liver Immunology. Liver Immunology 375 388 .
A. Mouihate, T. F. Horn & Q. J. Pittman. (2006) Oxyresveratrol dampens neuroimmune responses in vivo: a selective effect on TNF-α. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 291:5, pages R1215-R1221.
Crossref
Huang-Ge Zhang, Cunren Liu, Kaihun Su, Shaohua Yu, Liming Zhang, Shuangqin Zhang, Jianhua Wang, Xu Cao, William Grizzle & Robert P. Kimberly. (2006) A Membrane Form of TNF-α Presented by Exosomes Delays T Cell Activation-Induced Cell Death. The Journal of Immunology 176:12, pages 7385-7393.
Crossref
Yasir A. W. Skeiky & Jerald C. Sadoff. (2006) Advances in tuberculosis vaccine strategies. Nature Reviews Microbiology 4:6, pages 469-476.
Crossref
Eric F. Morand, Michelle Leech & Jürgen Bernhagen. (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nature Reviews Drug Discovery 5:5, pages 399-411.
Crossref
David M. Goldstein, Tom Alfredson, Jay Bertrand, Michelle F. Browner, Ken Clifford, Stacie A. Dalrymple, James Dunn, Jose Freire-Moar, Seth Harris, Sharada S. Labadie, JoAnn La Fargue, Jean Marc Lapierre, Susan Larrabee, Fujun Li, Eva Papp, Daniel McWeeney, Chakk Ramesha, Rick Roberts, David Rotstein, Bong San Pablo, Eric B. Sjogren, On-Yee So, Francisco X. Talamas, Will Tao, Alejandra Trejo, Armando Villasenor, Mary Welch, Teresa Welch, Paul Weller, Phyllis E. Whiteley, Kelly Young & Sheila Zipfel. (2006) Discovery of S -[5-Amino-1-(4-fluorophenyl)-1 H -pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an Orally Bioavailable and Highly Selective Inhibitor of p38 Map Kinase . Journal of Medicinal Chemistry 49:5, pages 1562-1575.
Crossref
Alexandros Kolokotronis, Evanda Avramidou, Thomas Zaraboukas, Kalliopi Mandraveli, Stella Alexiou & Demetrios Antoniades. (2006) Oral tuberculosis associated with a treatment with anti-rheumatic drugs. Journal of Oral Pathology and Medicine 35:2, pages 123-125.
Crossref
Mario Cazzola & Riccardo Polosa. (2006) Anti-TNF-α and Th1 cytokine-directed therapies for the treatment of asthma. Current Opinion in Allergy & Clinical Immunology 6:1, pages 43-50.
Crossref
Xiaochun Jin & Robert W. GereauIVIV. (2006) Acute p38-Mediated Modulation of Tetrodotoxin-Resistant Sodium Channels in Mouse Sensory Neurons by Tumor Necrosis Factor-α. The Journal of Neuroscience 26:1, pages 246-255.
Crossref
Martijn A. Spruit, Rik Gosselink, Thierry Troosters, Ahmad Kasran, Monique Van Vliet & Marc Decramer. (2005) Low-Grade Systemic Inflammation and the Response to Exercise Training in Patients With Advanced COPD. Chest 128:5, pages 3183-3190.
Crossref
Maria Zakharova & H. Kirk Ziegler. (2005) Paradoxical Anti-Inflammatory Actions of TNF-α: Inhibition of IL-12 and IL-23 via TNF Receptor 1 in Macrophages and Dendritic Cells. The Journal of Immunology 175:8, pages 5024-5033.
Crossref
W. Sipos, J. C. Duvigneau, F. Schmoll, B. Exel, G. Hofbauer, G. Baravalle, R. T. Hartl, M. Dobretsberger & P. Pietschmann. (2005) Characterization of the Cytokine Pattern of Porcine Bone Marrow-Derived Cells Treated with 1alpha,25(OH)2D3. Journal of Veterinary Medicine Series A 52:8, pages 382-387.
Crossref
Tohogo NonakaKanji FukudaChiaki Hamanishi. (2005) Can Human Plasma Redox State Be Used to Monitor the Progression of Rheumatoid Arthritis?. Antioxidants & Redox Signaling 7:9-10, pages 1405-1408.
Crossref
Cristina Russo & Riccardo Polosa. (2005) TNF-α as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clinical Science 109:2, pages 135-142.
Crossref
Daniel Wendling, Guewen-Edouard Materne, Fabrice Michel, Anne Lohse, Gaelle Lehuede, Eric Toussirot, Jacques Massol & Marie-Christine Woronoff-Lemsi. (2005) Évaluation du maintien thérapeutique de l’infliximab dans la polyarthrite rhumatoïde en pratique courante. Revue du Rhumatisme 72:7, pages 628-631.
Crossref
Daniel Wendling, Guewen-Edouard Materne, Fabrice Michel, Anne Lohse, Gaelle Lehuede, Eric Toussirot, Jacques Massol & Marie-Christine Woronoff-Lemsi. (2005) Infliximab continuation rates in patients with rheumatoid arthritis in everyday practice. Joint Bone Spine 72:4, pages 309-312.
Crossref
David S. Senchina, Dustin A. McCann, Jessica M. Asp, Jack A. Johnson, Joan E. Cunnick, Mark S. Kaiser & Marian L. Kohut. (2005) Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4 °C for four days. Clinica Chimica Acta 355:1-2, pages 67-82.
Crossref
Farida Djouad, Vanessa Fritz, Florence Apparailly, Pascale Louis-Plence, Claire Bony, Jacques Sany, Christian Jorgensen & Danièle Noël. (2005) Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis. Arthritis & Rheumatism 52:5, pages 1595-1603.
Crossref
Bernadette M. Saunders, Stephen Tran, Sigrid Ruuls, Jonathon D. Sedgwick, Helen Briscoe & Warwick J. Britton. (2005) Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection . The Journal of Immunology 174:8, pages 4852-4859.
Crossref
??ric Toussirot & Daniel Wendling. (2005) Late-Onset Ankylosing Spondylitis and Related Spondylarthropathies. Drugs & Aging 22:6, pages 451-469.
Crossref
D.L. Scott. (2005) Etanercept in arthritis. International Journal of Clinical Practice 59:1, pages 114-118.
Crossref
James G Tidball & Michelle Wehling-Henricks. (2004) Evolving Therapeutic Strategies for Duchenne Muscular Dystrophy: Targeting Downstream Events. Pediatric Research 56:6, pages 831-841.
Crossref
Tony Mets, Ivan Bautmans, Rose Njemini, Margareta Lambert & Christian Demanet. (2004) The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. The American Journal of Geriatric Pharmacotherapy 2:4, pages 230-238.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.